Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Granzyme A–producing T helper cells are critical for acute graft-versus-host disease
Sungtae Park, Brad Griesenauer, Hua Jiang, Djamilatou Adom, Pegah Mehrpouya-Bahrami, Srishti Chakravorty, Majid Kazemian, Tanbeena Imam, Rajneesh Srivastava, Tristan A. Hayes, Julian Pardo, Sarath Chandra Janga, Sophie Paczesny, Mark H. Kaplan, Matthew R. Olson
Sungtae Park, Brad Griesenauer, Hua Jiang, Djamilatou Adom, Pegah Mehrpouya-Bahrami, Srishti Chakravorty, Majid Kazemian, Tanbeena Imam, Rajneesh Srivastava, Tristan A. Hayes, Julian Pardo, Sarath Chandra Janga, Sophie Paczesny, Mark H. Kaplan, Matthew R. Olson
View: Text | PDF
Research Article Immunology Inflammation

Granzyme A–producing T helper cells are critical for acute graft-versus-host disease

  • Text
  • PDF
Abstract

Acute graft-versus-host disease (aGVHD) can occur after hematopoietic cell transplant in patients undergoing treatment for hematological malignancies or inborn errors. Although CD4+ T helper (Th) cells play a major role in aGVHD, the mechanisms by which they contribute, particularly within the intestines, have remained elusive. We have identified a potentially novel subset of Th cells that accumulated in the intestines and produced the serine protease granzyme A (GrA). GrA+ Th cells were distinct from other Th lineages and exhibited a noncytolytic phenotype. In vitro, GrA+ Th cells differentiated in the presence of IL-4, IL-6, and IL-21 and were transcriptionally unique from cells cultured with either IL-4 or the IL-6/IL-21 combination alone. In vivo, both STAT3 and STAT6 were required for GrA+ Th cell differentiation and played roles in maintenance of the lineage identity. Importantly, GrA+ Th cells promoted aGVHD-associated morbidity and mortality and contributed to crypt destruction within intestines but were not required for the beneficial graft-versus-leukemia effect. Our data indicate that GrA+ Th cells represent a distinct Th subset and are critical mediators of aGVHD.

Authors

Sungtae Park, Brad Griesenauer, Hua Jiang, Djamilatou Adom, Pegah Mehrpouya-Bahrami, Srishti Chakravorty, Majid Kazemian, Tanbeena Imam, Rajneesh Srivastava, Tristan A. Hayes, Julian Pardo, Sarath Chandra Janga, Sophie Paczesny, Mark H. Kaplan, Matthew R. Olson

×

Figure 7

Th-derived GrA contributes to immunopathology during aGVHD.

Options: View larger image (or click on image) Download as PowerPoint
Th-derived GrA contributes to immunopathology during aGVHD.
(A) BALB/c m...
(A) BALB/c mice received syngeneic (Syn, n = 11) or C57BL/6 bone marrow with purified CD8+ and CD4+ T cells from WT or Gzma–/– C57BL/6 mice (WT CD4+/WT CD8+, n = 27; Gzma–/– CD4+/WT CD8+, n = 30; WT CD4+/Gzma–/– CD8+, n = 15). LI cells were harvested (at day 10 post-HCT) and assessed for GrA production by CD3+ cells by flow cytometry. Representative plots are gated on CD3+ cells (left panel), and the frequency of GrA+CD3+CD4+ T cells was quantified (right panel) based on the flow cytometry plots. Clinical scores and survival curves (B) from BALB/c recipient mice after HCT as per panel A. C3.SW-H2b/SnJ mice received bone marrow and T cells as per panel A. (C) Representative contour plots depict GrA+ T cells from the LI and the frequencies of GrA+CD4+ T cells in recipient mice isolated from the liver, SI, and LI. (D) Clinical scores and survival plot of C3.SW-H2b/SnJ that received WT (n = 14) or Gzma–/– CD4+ T cells (n = 14). Clinical score and survival plots represent pooled data across multiple experiments with mouse numbers indicated. Error bars represent standard deviation of the mean. *P < 0.05 by Student’s t test in B and D. Statistical significance in survival plots was performed by log-rank test (see Methods). One-way ANOVA with Tukey’s posttest was used to determine statistical significance in A and C.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts